SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

院内感染コントロール市場

出版：MarketsandMarkets

Hospital Acquired Infection Control Market by Product & Service [Sterilization (Equipment, Services), Disinfectants (Hand, Skin, Surface, Wipes, Sprays)], End User (Hospitals, Nursing Homes, Diagnostic Centers), COVID-19 Impact – Global Forecast to 2026院内感染制御市場[滅菌（機器、サービス）、消毒剤（手、皮膚、表面、ワイプ、スプレー）]、エンドユーザー（病院、ナーシングホーム、診断センター）、COVID-19の影響-世界的な予測2026年までの世界市場予測
種別英文調査報告書
出版MarketsandMarkets
出版年月2021年8 月
ページ数297
図表数231
–
レポート目次 お問合せ
–The hospital acquired infection control market is projected to reach USD 31.3 billion by 2026 from USD 29.1 billion in 2021, at a CAGR of 1.5% during the forecast period. The growth of the hospital acquired infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19. The increasing use of E-beam sterilization, reintroduction of ethylene oxide sterilization, and the growing healthcare industry and outsourcing of operation to emerging countries are expected to offer high-growth opportunities for market players during the forecast period.Currently, with the surge in COVID-19 cases, there is an increasing focus on personal hygiene along with the increasing production of medical nonwovens and single-use products such as face masks and gloves. This is further expected to drive the growth of the hospital acquired infection control market in the coming years. On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of endoscope reprocessing and limited reimbursement in developing countries and end-user noncompliance with sterilization standards, is expected to restrain the growth of this market.The sterilization segment is expected to grow at the highest CAGR during the forecast periodBased on the products and services used in the control of HAIs, the hospital acquired infection control market is segmented into sterilization, disinfectors, endoscope reprocessing products, disinfectants, protective barriers, and other infection control products. The sterilization segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the growing incidence of chronic diseases and pandemics (such as COVID-19), the increasing need to reduce surgical-site infections (SSIs), and the growing number of surgeries performed worldwide. Increasing initiatives and regulatory actions taken by governments in various countries to fortify hospitals with essential infection control standards to prevent the spread of HAIs are also expected to support market growth.The hospitals & ICUs segment is expected to account for the largest share of the hospital acquired infection control marketBased on end user, the hospital acquired infection control market has been segmented into hospitals & intensive care units (ICUs), ambulatory surgical and diagnostic centers, nursing homes and maternity centers, and other end users (dental clinics, trauma centers, and clinical laboratories). The hospitals & ICUs segment accounted for the largest share of the hospital acquired infection control market in 2020. Growth in this market is majorly attributed to the rising prevalence of HAIs, increasing adoption of single-use medical devices, and rising number of surgical procedures worldwide.Asia Pacific is expected to account for the highest CAGR for players operating in the hospital acquired infection control marketThe Asia Pacific hospital acquired infection control market is expected to grow at the highest CAGR from 2021 to 2026. Most of the growth in the hospital acquired infection control market is expected from the emerging countries across the Asia Pacific. The rising number of surgical procedures conducted annually, favorable government regulations, the large patient population, and the rising incidence of COVID-19 are expected to drive the growth of the APAC market during the forecast period.Break of primary participants was as mentioned below:• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%• By Designation – C-level–35%, Director-level–25%, Others–40%• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%Key players in the Hospital Acquired Infection Control marketThe key players operating in the hospital acquired infection control market include STERIS plc (US), Sotera Health Company (US), Getinge AB (Sweden), Advanced Sterilization Products (ASP) (US), Ecolab Inc. (US), 3M Company (US), MATACHANA GROUP (Spain), MMM Group (Germany), Belimed AG (Switzerland), Reckitt Benckiser (UK), Metrex Research LLC (UK), Miele Group (Germany), Pal International (UK), MELAG Medizintechnik GmbH & Co. KG (Germany), Contec, Inc. (US), MEDALKAN (Greece), Systec GmbH (Germany), C.B.M. S.r.l. Medical Equipment (Italy), Continental Equipment Company (US), and BGS Beta-Gamma-Service GmbH & Co. KG (Germany).Research Coverage:The report analyzes the hospital acquired infection control market and aims at estimating the market size and future growth potential of this market based on various segments such as products and services, end user, and region. The report also includes a product portfolio matrix of various hospital acquired infection services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product & service offerings, and key market strategies.Reasons to Buy the ReportThe report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.This report provides insights into the following pointers:• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global hospital acquired infection control market. The report analyzes this market by products and services, and end user• Service Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global hospital acquired infection control market• Market Development: Comprehensive information on the lucrative emerging markets by products and services, and end user• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global hospital acquired infection control market• Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, competitive leadership mapping, and capabilities of leading players in the global hospital acquired infection control market.目次1 INTRODUCTION 311.1 OBJECTIVES OF THE STUDY 311.2 MARKET DEFINITION & SCOPE 311.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 321.2.2 MARKET SEGMENTATION 32FIGURE 1 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SEGMENTATION 321.2.3 YEARS CONSIDERED FOR THE STUDY 331.3 CURRENCY 33TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 331.4 STAKEHOLDERS 342 RESEARCH METHODOLOGY 352.1 RESEARCH APPROACH 352.2 RESEARCH METHODOLOGY DESIGN 35FIGURE 2 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: RESEARCH DESIGN 352.2.1 SECONDARY RESEARCH 362.2.1.1 Key data from secondary sources 372.2.2 PRIMARY DATA 38FIGURE 3 PRIMARY SOURCES 382.2.2.1 Key data from primary sources 392.2.2.2 Insights from primary experts 39FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 402.3 MARKET SIZE ESTIMATION: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 41FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION 42FIGURE 8 TOP-DOWN APPROACH 43FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET (2021–2026) 44FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 452.4 MARKET BREAKDOWN & DATA TRIANGULATION 46FIGURE 11 DATA TRIANGULATION METHODOLOGY 462.5 MARKET SHARE ESTIMATION 472.6 ASSUMPTIONS FOR THE STUDY 472.7 LIMITATIONS 472.7.1 METHODOLOGY-RELATED LIMITATIONS 472.8 RISK ASSESSMENT 48TABLE 2 RISK ASSESSMENT: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 483 EXECUTIVE SUMMARY 49FIGURE 12 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION) 50FIGURE 13 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS,BY TYPE, 2021 VS. 2026 (USD MILLION) 50FIGURE 14 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS,BY FORMULATION, 2021 VS. 2026 (USD MILLION) 51FIGURE 15 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER,2021 VS. 2026 (USD MILLION) 52FIGURE 16 GEOGRAPHIC ANALYSIS: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 534 PREMIUM INSIGHTS 554.1 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET OVERVIEW 55FIGURE 17 GROWING INCIDENCE OF HAIS AND INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH 554.2 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER AND COUNTRY 56FIGURE 18 HOSPITALS & ICUS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET IN 2020 564.3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 574.4 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION (2019–2026) 58FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET DURING THE FORECAST PERIOD 584.5 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: DEVELOPED VS. DEVELOPING MARKETS 59FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURINGTHE FORECAST PERIOD 595 MARKET OVERVIEW 605.1 INTRODUCTION 605.2 MARKET DYNAMICS 60TABLE 3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: IMPACT ANALYSIS 605.2.1 MARKET DRIVERS 615.2.1.1 High incidence of hospital-acquired infections (HAIs) 615.2.1.2 Increasing number of surgical procedures 63TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 635.2.1.3 Growing geriatric population and the increasing incidence of chronic diseases 645.2.1.4 Technological advancements in sterilization equipment 655.2.1.5 Growing awareness of environmental & personal hygiene due to COVID-19 665.2.2 MARKET RESTRAINTS 675.2.2.1 Concerns regarding the safety of reprocessed instruments 675.2.2.2 Adverse effects of chemical disinfectants 675.2.2.3 High cost of endoscopy reprocessing and limited reimbursement in developing countries 685.2.3 MARKET OPPORTUNITIES 685.2.3.1 Reintroduction of ethylene oxide sterilization as a disinfectant in healthcare settings 685.2.3.2 Rising adoption of single-use medical nonwovens and devices 695.2.3.3 Growing healthcare industry and outsourcing of operations to emerging countries 69FIGURE 22 INDIA: HEALTHCARE SECTOR GROWTH TREND (USD BILLION) 70FIGURE 23 INDIA: NUMBER OF HOSPITALIZATIONS DUE TO VARIOUS DISEASES 705.2.4 MARKET CHALLENGES 715.2.4.1 Complications associated with hospital-acquired infection control procedures 715.2.4.2 End-user noncompliance with sterilization standards 71TABLE 5 US: DECREASING COMPLIANCE AMONG END USERS 725.2.4.3 Development of alternative technologies for surface disinfection 726 INDUSTRY INSIGHTS 736.1 INTRODUCTION 736.2 INDUSTRY TRENDS 736.2.1 INCREASING ADOPTION OF STERILIZATION USING NO2 736.2.2 ROBOTICS UTILIZATION FOR DISINFECTION 746.2.3 GROWING POPULARITY OF SINGLE-USE PRODUCTS 756.2.4 LAYERING/BUNDLING IN INFECTION PREVENTION 766.3 REGULATORY ANALYSIS 766.3.1 REGULATORY JURISDICTION 76TABLE 6 FDA- AND EPA-REGISTERED PRODUCT CATEGORIES 776.3.2 BY REGION 776.3.2.1 North America 776.3.2.1.1 US 77FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES 786.3.2.1.2 Canada 79TABLE 7 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT/DEVICES AND REQUIRED LEVEL OF PROCESSING/REPROCESSING 806.3.2.2 Europe 81TABLE 8 STERILIZATION STANDARDS IN THE EUROPEAN UNION 81FIGURE 25 CE MARKING FOR REPROCESSED MEDICAL DEVICES 826.3.2.3 Asia Pacific 826.3.2.3.1 Japan 82TABLE 9 SOME GUIDELINES FOLLOWED UNDER ISO IN JAPAN 83TABLE 10 SPECIFICATIONS OF BIS RECOMMENDED FOR USE IN STERILIZATION PROCESSES 836.3.2.3.2 Australia 846.3.2.4 Latin America 846.3.3 ENFORCEMENT POLICY FOR STERILIZERS AND DISINFECTANT DEVICES DURING COVID-19 846.3.3.1 Sterilizers 84TABLE 11 CLASSIFICATION REGULATIONS FOR STERILIZERS 856.3.3.2 Disinfectant devices 85TABLE 12 CLASSIFICATION REGULATION FOR DISINFECTANT DEVICES 856.4 TECHNOLOGY ANALYSIS 866.4.1 KEY TECHNOLOGIES 866.4.2 COMPLEMENTARY TECHNOLOGIES 876.4.3 ADJACENT TECHNOLOGIES 876.5 PORTER’S FIVE FORCES ANALYSIS 88TABLE 13 PORTER’S FIVE FORCES ANALYSIS (2020): HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 886.5.1 THREAT FROM NEW ENTRANTS 886.5.2 THREAT FROM SUBSTITUTES 896.5.3 BARGAINING POWER OF SUPPLIERS 896.5.4 BARGAINING POWER OF BUYERS 896.5.5 INTENSITY OF COMPETITIVE RIVALRY 896.6 ECOSYSTEM ANALYSIS 90FIGURE 26 INFECTION CONTROL MARKET: ECOSYSTEM ANALYSIS 906.7 VALUE CHAIN ANALYSIS 91FIGURE 27 INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS 916.8 TRADE DATA 926.8.1 EXPORT DATA (USD) 926.8.2 IMPORT DATA (USD) 926.9 PATENT ANALYSIS 936.9.1 PATENT PUBLICATION TRENDS FOR HOSPITAL-ACQUIRED INFECTION CONTROL 93FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2011–JULY 2021) 936.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 93FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HOSPITAL-ACQUIRED INFECTION CONTROL PATENTS (JANUARY 2011–JULY 2021) 94FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR HOSPITAL-ACQUIRED INFECTION CONTROL PATENTS (JANUARY 2011–JULY 2021) 95TABLE 14 LIST OF FEW PATENTS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, 2020–2021 956.10 IMPACT OF COVID-19 ON THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 967 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE 987.1 INTRODUCTION 99TABLE 15 COMMONLY USED INFECTION CONTROL CHEMICALS 99TABLE 16 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 1017.2 PROTECTIVE BARRIERS 1017.2.1 RISING ADOPTION OF NONWOVENS IN SURGICAL INTERVENTIONS TO PROPEL MARKET GROWTH 101TABLE 17 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY COUNTRY, 2019–2026 (USD MILLION) 1037.3 STERILIZATION 103TABLE 18 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION,BY TYPE, 2019–2026 (USD MILLION) 104TABLE 19 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION,BY COUNTRY, 2019–2026 (USD MILLION) 1047.3.1 STERILIZATION EQUIPMENT 1057.3.1.1 Effectiveness of sterilization equipment in sterilizing heat-sensitive products is expected to boost the market growth 105TABLE 20 STERILIZATION EQUIPMENT MARKET, BY COUNTRY,2019–2026 (USD MILLION) 1067.3.2 STERILIZATION SERVICES 1067.3.2.1 Increasing prevalence of HAIs and rising surgical interventions to drive market growth 106TABLE 21 STERILIZATION SERVICES MARKET, BY COUNTRY,2019–2026 (USD MILLION) 1077.3.3 STERILIZATION CONSUMABLES & ACCESSORIES 1077.3.3.1 Low cost and efficacy of sterilization consumables & accessories in monitoring the sterilization process to drive market growth 107TABLE 22 STERILIZATION CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 1097.4 DISINFECTANTS 109TABLE 23 JOINT COMMISSION STANDARDS FOR INFECTION CONTROL AND PREVENTION 110TABLE 24 COMMON DISINFECTANTS USED IN HEALTHCARE SETTINGS 111TABLE 25 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS,BY COUNTRY, 2019–2026 (USD MILLION) 1127.4.1 DISINFECTANTS, BY TYPE 112TABLE 26 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS,BY TYPE, 2019–2026 (USD MILLION) 1137.4.1.1 Hand disinfectants 1137.4.1.1.1 Increasing availability of various hand disinfection options to aid market growth 113TABLE 27 HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 114TABLE 28 HAND DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 1157.4.1.2 Surface disinfectants 1157.4.1.2.1 Surface disinfectants limit the transfer of microorganisms that can occur through hand contact between contaminated surfaces and patients or staff 115TABLE 29 SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 116TABLE 30 SURFACE DISINFECTANTS MARKET, BY COUNTRY,2019–2026 (USD MILLION) 1177.4.1.3 Skin disinfectants 1177.4.1.3.1 Growing awareness about different HAIs and SSIs to aid market growth 117TABLE 31 SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 118TABLE 32 SKIN DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 1187.4.1.4 Instrument disinfectants 1197.4.1.4.1 Increasing number of surgeries and government initiatives for ensuring cleanliness in healthcare facilities are boosting the instrument disinfectants market 119TABLE 33 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT AND THE REQUIRED LEVEL OF REPROCESSING 120TABLE 34 INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY,2019–2026 (USD MILLION) 1207.4.2 DISINFECTANTS, BY FORMULATION 121TABLE 35 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS,BY FORMULATION, 2019–2026 (USD MILLION) 1217.4.2.1 Liquid disinfectants 1217.4.2.1.1 Liquid formulations are inexpensive and are an effective disinfection solution for porous and nonporous surfaces 121TABLE 36 LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 122TABLE 37 LIQUID DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 1237.4.2.2 Disinfectant wipes 1237.4.2.2.1 Wipes help eliminate a broad spectrum of bacteria, viruses, and allergens 123TABLE 38 DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS 124TABLE 39 DISINFECTANT WIPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 1257.4.2.3 Disinfectant sprays 1257.4.2.3.1 Disinfectant sprays are used in fogging techniques for antimicrobial control in hospital rooms and operation theaters 125TABLE 40 DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS 126TABLE 41 DISINFECTANT SPRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 1267.5 DISINFECTORS 1277.5.1 GROWING NEED TO REDUCE THE SPREAD OF HAIS IS DRIVING MARKET GROWTH 127TABLE 42 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTORS,BY COUNTRY, 2019–2026 (USD MILLION) 1287.6 ENDOSCOPE REPROCESSING PRODUCTS 1287.6.1 INCREASING NUMBER OF ENDOSCOPY PROCEDURES CONDUCTED TO DRIVE MARKET GROWTH 128TABLE 43 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY COUNTRY, 2019–2026 (USD MILLION) 1297.7 OTHER INFECTION CONTROL PRODUCTS 130TABLE 44 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER INFECTION CONTROL PRODUCTS, BY COUNTRY, 2019–2026 (USD MILLION) 1308 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER 1318.1 INTRODUCTION 132TABLE 45 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER,2019–2026 (USD MILLION) 1328.2 IMPACT OF COVID-19 ON THE END USERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 1338.3 HOSPITALS & INTENSIVE CARE UNITS (ICUS) 1338.3.1 HIGH PREVALENCE OF HAIS TO DRIVE THE DEMAND FOR DISINFECTION AND STERILIZATION PRODUCTS AMONG HOSPITALS & INTENSIVE CARE UNITS 133TABLE 46 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HOSPITALS & INTENSIVE CARE UNITS, BY COUNTRY, 2019–2026 (USD MILLION) 1358.4 AMBULATORY SURGERY & DIAGNOSTIC CENTERS 1368.4.1 GROWING NUMBER OF OUTPATIENTS AND AWARENESS OF MINIMALLY INVASIVE SURGERIES IS EXPECTED TO PROPEL MARKET GROWTH 136TABLE 47 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR AMBULATORY SURGERY & DIAGNOSTIC CENTERS, BY COUNTRY,2019–2026 (USD MILLION) 1378.5 NURSING HOMES & MATERNITY CENTERS 1388.5.1 GROWING NEED TO ENSURE THE SAFETY OF ELDERLY PATIENTS AND RISING SURGICAL PROCEDURES IN WOMEN TO DRIVE THE ADOPTION OF HAI CONTROL PRODUCTS IN THIS END-USER SEGMENT 138TABLE 48 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR NURSING HOMES & MATERNITY CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 1398.6 OTHER END USERS 140TABLE 49 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 1419 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION 1429.1 INTRODUCTION 143FIGURE 31 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: GEOGRAPHIC SNAPSHOT (2020) 143TABLE 50 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION,2019–2026 (USD MILLION) 1449.2 IMPACT OF COVID-19 ON THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 1449.3 NORTH AMERICA 146TABLE 51 NATIONAL ACUTE CARE HOSPITAL HAI METRICS 147FIGURE 32 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SNAPSHOT 147TABLE 52 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY COUNTRY, 2019–2026 (USD MILLION) 148TABLE 53 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 148TABLE 54 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 148TABLE 55 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 149TABLE 56 NORTH AMERICA: DISINFECTANTS MARKET, BY TYPE,2019–2026 (USD MILLION) 149TABLE 57 NORTH AMERICA: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 149TABLE 58 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY END USER, 2019–2026 (USD MILLION) 1509.3.1 US 1509.3.1.1 Increasing prevalence of HAIs, high R&D expenditure, and the presence of well-established pharmaceutical, medical devices, and hospital industries to drive market growth 150TABLE 59 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 151TABLE 60 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 151TABLE 61 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 152TABLE 62 US: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 152TABLE 63 US: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION) 152TABLE 64 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1539.3.2 CANADA 1539.3.2.1 High prevalence of HAIs to increase the adoption of infection control products in the country 153TABLE 65 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 154TABLE 66 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 155TABLE 67 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 155TABLE 68 CANADA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 155TABLE 69 CANADA: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 156TABLE 70 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1569.4 EUROPE 156TABLE 71 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 157TABLE 72 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 157TABLE 73 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 158TABLE 74 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 158TABLE 75 EUROPE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 158TABLE 76 EUROPE: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 159TABLE 77 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1599.4.1 GERMANY 1599.4.1.1 Rising incidence of nosocomial infections and chronic diseases to drive growth in the market in Germany 159TABLE 78 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 160TABLE 79 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 160TABLE 80 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 161TABLE 81 GERMANY: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 161TABLE 82 GERMANY: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 161TABLE 83 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY END USER, 2019–2026 (USD MILLION) 1629.4.2 FRANCE 1629.4.2.1 High healthcare spending in the country to favor market growth 162TABLE 84 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 163TABLE 85 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 163TABLE 86 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 164TABLE 87 FRANCE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164TABLE 88 FRANCE: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 164TABLE 89 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1659.4.3 UK 1659.4.3.1 Rising number of surgical procedures to drive the market growth in the UK 165TABLE 90 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 166TABLE 91 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 167TABLE 92 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 167TABLE 93 UK: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 167TABLE 94 UK: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION) 168TABLE 95 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1689.4.4 ITALY 1689.4.4.1 Improving quality and accessibility to medical care and technologies to support market growth 168TABLE 96 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 169TABLE 97 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 169TABLE 98 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 170TABLE 99 ITALY: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 170TABLE 100 ITALY: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 170TABLE 101 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1719.4.5 SPAIN 1719.4.5.1 Rising incidence of chronic disorders to drive market growth 171TABLE 102 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 172TABLE 103 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 172TABLE 104 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 173TABLE 105 SPAIN: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 173TABLE 106 SPAIN: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 173TABLE 107 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1749.4.6 REST OF EUROPE 174TABLE 108 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 175TABLE 109 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 175TABLE 110 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 175TABLE 111 ROE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 176TABLE 112 ROE: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 176TABLE 113 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1769.5 ASIA PACIFIC 177FIGURE 33 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SNAPSHOT 178TABLE 114 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY COUNTRY, 2019–2026 (USD MILLION) 179TABLE 115 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 179TABLE 116 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 179TABLE 117 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 180TABLE 118 ASIA PACIFIC: DISINFECTANTS MARKET, BY TYPE,2019–2026 (USD MILLION) 180TABLE 119 ASIA PACIFIC: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 180TABLE 120 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY END USER, 2019–2026 (USD MILLION) 1819.5.1 JAPAN 1819.5.1.1 Rising standard of care due to the increasing healthcare expenditure to support market growth 181TABLE 121 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 182TABLE 122 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 182TABLE 123 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 183TABLE 124 JAPAN: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 183TABLE 125 JAPAN: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 183TABLE 126 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1849.5.2 CHINA 1849.5.2.1 China is the fastest-growing market for hospital-acquired infection control products and services 184FIGURE 34 CHINA: TOTAL NUMBER OF HOSPITAL BEDS (2009–2019) 185TABLE 127 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 186TABLE 128 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 186TABLE 129 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 186TABLE 130 CHINA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 187TABLE 131 CHINA: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 187TABLE 132 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1879.5.3 INDIA 1889.5.3.1 Large patient population to support the growth of the hospital-acquired infection control market in the country 188TABLE 133 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 189TABLE 134 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 189TABLE 135 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 189TABLE 136 INDIA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 190TABLE 137 INDIA: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 190TABLE 138 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1909.5.4 REST OF ASIA PACIFIC 191FIGURE 35 NUMBER OF INBOUND VISITORS TO SOUTH KOREA FROM2000 TO 2020 (IN MILLIONS) 192TABLE 139 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 192TABLE 140 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 193TABLE 141 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 193TABLE 142 ROAPAC: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 193TABLE 143 ROAPAC: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 194TABLE 144 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 1949.6 LATIN AMERICA 1949.6.1 RISING NUMBER OF COSMETIC SURGERIES IN THE REGION TO DRIVE THE ADOPTION OF INFECTION CONTROL PRODUCTS 194TABLE 145 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 195TABLE 146 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 195TABLE 147 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 196TABLE 148 LATIN AMERICA: DISINFECTANTS MARKET, BY TYPE,2019–2026 (USD MILLION) 196TABLE 149 LATIN AMERICA: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 196TABLE 150 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,BY END USER, 2019–2026 (USD MILLION) 1979.7 MIDDLE EAST & AFRICA 1979.7.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH 197TABLE 151 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 198TABLE 152 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 199TABLE 153 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 199TABLE 154 MIDDLE EAST & AFRICA: DISINFECTANTS MARKET, BY TYPE,2019–2026 (USD MILLION) 199TABLE 155 MIDDLE EAST & AFRICA: DISINFECTANTS MARKET, BY FORMULATION,2019–2026 (USD MILLION) 200TABLE 156 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 20010 COMPETITIVE LANDSCAPE 20110.1 OVERVIEW 20110.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 20110.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 20210.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 203FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 20310.4 MARKET SHARE ANALYSIS 204FIGURE 37 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2020 204TABLE 157 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: DEGREE OF COMPETITION 20510.5 COMPETITIVE BENCHMARKING 20610.5.1 COMPANY PRODUCT/SERVICE FOOTPRINT 206TABLE 158 COMPANY PRODUCT OFFERING FOOTPRINT (20 COMPANIES) 207TABLE 159 COMPANY END-USER FOOTPRINT (20 COMPANIES) 208TABLE 160 COMPANY REGION FOOTPRINT (20 COMPANIES) 20910.6 COMPETITIVE LEADERSHIP MAPPING 21010.6.1 STARS 21010.6.2 EMERGING LEADERS 21010.6.3 PERVASIVE PLAYERS 21010.6.4 PARTICIPANTS 210FIGURE 38 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 21110.7 COMPETITIVE SCENARIO 21210.7.1 PRODUCT LAUNCHES & APPROVALS 212TABLE 161 PRODUCT LAUNCHES & APPROVALS, 2018–2021 21210.7.2 DEALS 213TABLE 162 DEALS, 2018–2021 21310.7.3 OTHER DEVELOPMENTS 214TABLE 163 OTHER DEVELOPMENTS, 2018–2021 21411 COMPANY PROFILES 21511.1 KEY PLAYERS 215(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*11.1.1 STERIS PLC 215TABLE 164 STERIS PLC: BUSINESS OVERVIEW 215FIGURE 39 STERIS PLC: COMPANY SNAPSHOT (2021) 21611.1.2 SOTERA HEALTH COMPANY 223TABLE 165 SOTERA HEALTH COMPANY: BUSINESS OVERVIEW 223FIGURE 40 SOTERA HEALTH COMPANY: COMPANY SNAPSHOT (2020) 22411.1.3 GETINGE AB 227TABLE 166 GETINGE AB: BUSINESS OVERVIEW 227FIGURE 41 GETINGE AB: COMPANY SNAPSHOT (2020) 22811.1.4 ADVANCED STERILIZATION PRODUCTS (ASP) 236TABLE 167 ADVANCED STERILIZATION PRODUCTS: BUSINESS OVERVIEW 236FIGURE 42 FORTIVE CORPORATION: COMPANY SNAPSHOT (2020) 23711.1.5 ECOLAB INC. 240TABLE 168 ECOLAB INC.: BUSINESS OVERVIEW 240FIGURE 43 ECOLAB INC.: COMPANY SNAPSHOT (2020) 24111.1.6 3M COMPANY 250TABLE 169 3M COMPANY: BUSINESS OVERVIEW 250FIGURE 44 3M COMPANY: COMPANY SNAPSHOT (2020) 25111.1.7 MATACHANA GROUP 257TABLE 170 MATACHANA GROUP: BUSINESS OVERVIEW 25711.1.8 MMM GROUP 260TABLE 171 MMM GROUP: BUSINESS OVERVIEW 26011.1.9 BELIMED AG (A SUBSIDIARY OF METALL ZUG GROUP) 262TABLE 172 BELIMED AG: BUSINESS OVERVIEW 262FIGURE 45 METALL ZUG GROUP: COMPANY SNAPSHOT (2020) 26311.1.10 RECKITT BENCKISER 266TABLE 173 RECKITT BENCKISER: BUSINESS OVERVIEW 266FIGURE 46 RECKITT BENCKISER: COMPANY SNAPSHOT (2020) 26711.1.11 METREX RESEARCH LLC (A SUBSIDIARY OF DANAHER CORPORATION) 269TABLE 174 METREX RESEARCH: BUSINESS OVERVIEW 269FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 27011.1.12 MIELE GROUP 273TABLE 175 MIELE GROUP: BUSINESS OVERVIEW 273FIGURE 48 MIELE GROUP: COMPANY SNAPSHOT (2020) 27411.1.13 PAL INTERNATIONAL 280TABLE 176 PAL INTERNATIONAL: BUSINESS OVERVIEW 28011.1.14 MELAG MEDIZINTECHNIK GMBH & CO. KG 282TABLE 177 MELAG MEDIZINTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW 28211.1.15 CONTEC, INC. 284TABLE 178 CONTEC, INC.: BUSINESS OVERVIEW 28411.1.16 MEDALKAN 287TABLE 179 MEDALKAN: BUSINESS OVERVIEW 28711.1.17 SYSTEC GMBH 289TABLE 180 SYSTEC GMBH: BUSINESS OVERVIEW 28911.1.18 C.B.M. S.R.L. MEDICAL EQUIPMENT 290TABLE 181 C.B.M. S.R.L. MEDICAL EQUIPMENT: BUSINESS OVERVIEW 29011.1.19 CONTINENTAL EQUIPMENT COMPANY 291TABLE 182 CONTINENTAL EQUIPMENT COMPANY: BUSINESS OVERVIEW 29111.1.20 BETA-GAMMA-SERVICE GMBH & CO. KG 292TABLE 183 BETA-GAMMA-SERVICE GMBH & CO. KG: BUSINESS OVERVIEW 292*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.11.2 OTHER PLAYERS 29311.2.1 MIDWEST STERILIZATION CORPORATION 29311.2.2 BLUE LINE STERILIZATION SERVICES LLC 29311.2.3 STERIPACK GROUP 29411.2.4 STERI-TEK 29411.2.5 STERILIZATION SERVICES 29512 APPENDIX 29612.1 INSIGHTS FROM INDUSTRY EXPERTS 29612.2 DISCUSSION GUIDE 29712.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 30112.4 AVAILABLE CUSTOMIZATIONS 30312.5 RELATED REPORTS 30312.6 AUTHOR DETAILS 304

お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    医療・医薬の最新記事8件